Clinical trial

Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel

NCT00405717 · Shenyang Northern Hospital, Other · Completed

Key facts

NCT number NCT00405717
Title Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
Official title Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
Lead sponsor Shenyang Northern Hospital, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Ischemic Heart Disease, Acute Coronary Syndromes
Intervention type Drug
Interventions atorvastatin, pravastatin
Enrollment 1,300
Start date Feb 1, 2006
Primary completion May 1, 2008
Completion May 1, 2008
First posted Nov 30, 2006
Last update posted Nov 7, 2008
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies